A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

This observational study is collecting real-world data on how effective and safe a fixed-dose combination pill (pitavastatin/ezetimibe) is in patients with high cholesterol who are switching from statin-only therapy. The study will capture laboratory results from routine clinical visits to compare cholesterol levels before and after the switch. You may be eligible if you are 19 or older, have high cholesterol, have been on a stable statin (atorvastatin or rosuvastatin) for at least 3 months, and your doctor has already decided to switch you to the pitavastatin/ezetimibe combination. Participation involves your doctor collecting routine blood test results over time; no extra procedures or clinic visits beyond standard care are required. This summary was prepared using AI to help patients understand this research.